Tyra Biosciences Inc’s recently made public that its President and CEO Harris Todd unloaded Company’s shares for reported $1.18 million on Oct 18 ’24. In the deal valued at $27.01 per share,43,636 shares were sold. As a result of this transaction, Harris Todd now holds 1,375,011 shares worth roughly $30.15 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Harris Todd sold 19,084 shares, generating $532,451 in total proceeds. Upon selling the shares at $27.90, the President and CEO now owns 1,355,927 shares.
Before that, Harris Todd sold 33,297 shares. Tyra Biosciences Inc shares valued at $871,430 were divested by the President and CEO at a price of $26.17 per share. As a result of the transaction, Harris Todd now holds 1,434,041 shares, worth roughly $31.45 million.
BofA Securities upgraded its Tyra Biosciences Inc [TYRA] rating to a Buy from a a Neutral in a research note published on October 18, 2024; the price target was increased to $31 from $22. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid August with a ‘”an Overweight”‘ rating. BofA Securities also remained covering TYRA and has decreased its forecast on December 15, 2023 with a “Neutral” recommendation from previously “Buy” rating. Wedbush started covering the stock on June 30, 2023. It rated TYRA as “an Outperform”.
Price Performance Review of TYRA
On Friday, Tyra Biosciences Inc [NASDAQ:TYRA] saw its stock fall -23.35% to $21.93. Over the last five days, the stock has lost -19.76%. Tyra Biosciences Inc shares have risen nearly 58.34% since the year began. Nevertheless, the stocks have risen 92.37% over the past one year. While a 52-week high of $29.60 was reached on 10/24/24, a 52-week low of $10.38 was recorded on 01/05/24. SMA at 50 days reached $22.87, while 200 days put it at $18.99.
Levels Of Support And Resistance For TYRA Stock
The 24-hour chart illustrates a support level at 19.64, which if violated will result in even more drops to 17.35. On the upside, there is a resistance level at 24.19. A further resistance level may holdings at 26.45. The Relative Strength Index (RSI) on the 14-day chart is 41.92, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.49, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bearish at 76.78%. Stochastics %K at 67.98% indicates the stock is a holding.
How much short interest is there in Tyra Biosciences Inc?
A steep rise in short interest was recorded in Tyra Biosciences Inc stocks on 2024-10-15, dropping by -0.2 million shares to a total of 2.2 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.4 million shares. There was a decline of -8.95%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 03, 2023 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $17 price target.
